MedPath

Palliative Radiation Oncology Chief's Clinic

Terminated
Conditions
Malignant Disease
Metastasis
Interventions
Other: Data collection and analysis
Other: Quality of Life Questionnaire
Registration Number
NCT03995927
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The proposed study represents a quality improvement study of a recently-developed dedicated radiation oncology subspecialty clinic with the goal of improving timeliness of palliative radiation therapy and improving resident training in palliative care topics. The aim of this study is to evaluate the impact of this clinic on time to palliative radiation therapy following referral.

Detailed Description

Primary Objective:

• Determine whether interval between palliative radiation therapy referral and palliative radiation therapy initiation is shorter for participants treated in a dedicated palliative radiation oncology clinic compared to the same interval for participants treated in a general radiation oncology clinic (historical control). The investigators' hypothesis is that this interval will be significantly shorter among the Palliative Radiation Oncology Chief's Clinic participants compared to historical control.

Secondary Objectives:

* Determine whether each of the three component intervals within the overall interval from referral to treatment initiation (i.e., referral to consultation; consultation to simulation; simulation to treatment) is shorter for participants treated in a dedicated palliative radiation oncology clinic compared to the length of the same intervals for participants treated in a general radiation oncology clinic (historical control). The investigators' hypothesis is that each of these component intervals will be significantly shorter among the Palliative Radiation Oncology Chief's Clinic participants compared to historical control.

* Describe levels of and changes over time in patient-reported quality of life after palliative radiation therapy in the full sample, and in subgroups stratified by various radiation regimens. The investigators' hypothesis is that participants who receive a shorter course of palliative radiation (one day or five days) will have greater improvements in overall quality of life than participants who receive a ten-day course of palliative radiation.

* Determine median overall survival after palliative radiation therapy.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Age 18 years or older
  • Clinically or pathologically-defined malignant disease amenable to palliative radiotherapy.
Exclusion Criteria
  • Pregnancy. A verbal pregnancy denial will suffice.
  • No intention to treat with palliative radiation therapy following initial referral and consult.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Data collection/questionnaireQuality of Life QuestionnaireData collection for patient medical charts and patient fill out questionnaires first visit and post-treatment visits
Data collection/questionnaireData collection and analysisData collection for patient medical charts and patient fill out questionnaires first visit and post-treatment visits
Primary Outcome Measures
NameTimeMethod
Number of Days Between Referral and Start of Treatment3 months

Number of days between referral to palliative radiation therapy interval and start of palliative radiation therapy compared to historical control. Mean time from referral to the start of RT (measured in days) will be computed for our sample and compared to the historical control mean of 13.4 days using a two-sided one-sample t-test.

Secondary Outcome Measures
NameTimeMethod
Mean Time from Consultation to CT Simulation3 months

Mean time from consultation to CT simulation will be computed for our sample and compared to the historical control mean of 3.8 days.

Mean Time from CT Simulation to Palliative Radiation Start3 months

Mean time from CT simulation to start of PRT will be computed for our sample and compared to the historical control mean of 6.1 days.

Mean Time from Referral for Consultation3 months

Mean time from referral to consultation will be computed for our sample and compared to the historical control mean of 3.6 days.

Quality of Life Changes1 and 3 months after treatment completion

Levels of and changes in patient-reported overall quality of life as measured by the EORTC QLQ-C15-PAL (14 questions) at baseline and at 1-month and 3-month intervals after end of palliative radiation therapy. Quality of life score scale consists of 1 = not at all to 4 = very much. The higher the QOL score the greater change in the participant's quality of life.

Overall Survival6 months after treatment completion

Median overall survival (number of days between start of radiation therapy and death from any cause) will be estimated using the Kaplan-Meier method and compared (with a one-sample logrank test and assuming a Weibull distribution parameter of 1.0) to the median overall survival of n=134 days in our historical control.

Trial Locations

Locations (1)

Wake Forest Baptist Comprehensive Cancer Center

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath